Table 1.
Probe identifier | Gene symbol | Gene name | Relative changea | FDRb (%) | Correlation with LVMc | P valued |
---|---|---|---|---|---|---|
218730_s_at | OGN | Osteoglycin | 2.2 | 2.7 | 0.62 | 1.2 × 10−3 |
202766_s_at | FBN1 | Fibrillin 1 | 2.0 | 2.7 | 0.55 | 4.5 × 10−3 |
209621_s_at | PDLIM3 | PDZ and LIM domain 3 | 1.6 | 5.0 | 0.52 | 6.5 × 10−3 |
219087_at | ASPN | Asporin | 1.9 | 5.0 | 0.52 | 7.5 × 10−3 |
213646_x_at | TUBA1B | Tubulin, alpha 1b | 1.5 | 2.7 | 0.52 | 5.7 × 10−3 |
213765_at | MFAP5 | Microfibrillar associated protein 5 | 1.8 | 5.0 | 0.51 | 6.8 × 10−3 |
203570_at | LOXL1 | Lysyl oxidase-like 1 | 1.5 | 5.0 | 0.51 | 8.1 × 10−3 |
208782_at | FSTL1 | Follistatin-like 1 | 1.5 | 2.7 | 0.51 | 1.1 × 10−2 |
213867_x_at | ACTB | Actin, beta | 1.5 | 2.7 | 0.49 | 1.1 × 10−2 |
212614_at | ARID5B | AT rich interactive domain 5B | 1.6 | 2.7 | 0.49 | 9.9 × 10−3 |
216442_x_at | FN1 | Fibronectin 1 | 1.9 | 5.0 | 0.49 | 1.1 × 10−2 |
211750_x_at | TUBA1C | Tubulin, alpha 1c | 1.6 | 2.7 | 0.48 | 1.3 × 10−2 |
212582_at | OSBPL8 | Oxysterol binding protein-like 8 | 1.6 | 2.7 | 0.48 | 1.1 × 10−2 |
221729_at | COL5A2 | Collagen, type V, alpha 2 | 1.9 | 5.0 | 0.48 | 1.3 × 10−2 |
201843_s_at | EFEMP1 | EGF- fibulin-like extracellular matrix protein 1 | 1.8 | 5.0 | 0.48 | 1.2 × 10−2 |
202007_at | NID1 | Nidogen 1 | 1.6 | 2.7 | 0.47 | 1.6 × 10−2 |
203548_s_at | LPL | Lipoprotein lipase | 1.8 | 2.7 | 0.47 | 1.7 × 10−2 |
205547_s_at | TAGLN | Transgelin | 2.1 | 2.7 | 0.46 | 1.7 × 10−2 |
202552_s_at | CRIM1 | Cysteine rich transmembrane BMP regulator 1 | 1.6 | 3.9 | 0.46 | 1.9 × 10−2 |
201012_at | ANXA1 | Annexin A1 | 1.6 | 2.7 | 0.46 | 1.7 × 10−2 |
209460_at | ABAT | 4-aminobutyrate aminotransferase | 1.6 | 2.7 | 0.45 | 2.0 × 10−2 |
201302_at | ANXA4 | Annexin A4 | 1.5 | 3.9 | 0.44 | 2.1 × 10−2 |
219260_s_at | C17orf81 | Chromosome 17 open reading frame 81 | 1.5 | 2.7 | 0.44 | 2.4 × 10−2 |
209130_at | SNAP23 | Synaptosomal-associated protein, 23kda |
1.5 | 5.0 | 0.44 | 2.6 × 10−2 |
209392_at | ENPP2 | Ectonucleotide pyrophosphatase/ phosphodiesterase 2 |
1.6 | 2.7 | 0.43 | 2.7 × 10−2 |
200974_at | ACTA2 | Actin, alpha 2, smooth muscle, aorta | 1.6 | 2.7 | 0.43 | 2.8 × 10−2 |
210942_s_at | ST3GAL6 | ST3 beta-galactoside alpha-2,3-sialyltransferase 6 | 1.5 | 5.0 | 0.42 | 3.3 × 10−2 |
212063_at | CD44 | CD44 molecule | 1.9 | 3.9 | 0.42 | 3.0 × 10−2 |
212515_s_at | DDX3X | DEAD (Asp-Glu-Ala-Asp) box polypeptide 3, X-linked | 1.5 | 5.0 | 0.41 | 3.6 × 10−2 |
211509_s_at | RTN4 | Reticulon 4 | 1.6 | 3.9 | 0.41 | 3.7 × 10−2 |
209387_s_at | TM4SF1 | Transmembrane 4 L six family member 1 | 1.8 | 2.7 | 0.40 | 4.0 × 10−2 |
219922_s_at | LTBP3 | Latent transforming growth factor beta binding protein 3 | 1.5 | 5.0 | 0.40 | 4.3 × 10−2 |
202119_s_at | CPNE3 | Copine III | 1.5 | 3.9 | 0.40 | 4.8 × 10−2 |
210095_s_at | IGFBP3 | Insulin-like growth factor binding protein 3 | 1.7 | 2.7 | 0.39 | 5.0 × 10−2 |
Relative change in expression between subjects with low (≤93 g/m2) and high (≥142 g/m2) LVM in the study population.
False discovery rate for differential expression, estimated by SAM analysis.
Data are ranked according to decreasing values of the Pearson correlation with LVM (determined noninvasively by echocardiography).
Empirical P values for the correlations were calculated by 10,000 permutations.